Literature DB >> 25800808

Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.

Yasuhiko Ebina1, Nobuo Yaegashi, Hidetaka Katabuchi, Satoru Nagase, Yasuhiro Udagawa, Toru Hachisuga, Tsuyoshi Saito, Mikio Mikami, Yoichi Aoki, Hiroyuki Yoshikawa.   

Abstract

The second edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine cervical cancer was published in 2011. The guidelines comprise eight chapters and five algorithms. They were prepared by consensus among the members of the Japan Society of Gynecologic Oncology Guidelines Formulation Committee and Evaluation Committee and are based on a careful review of the evidence obtained from the literature, health insurance system, and actual clinical settings in Japan. The highlights of the 2011 revision are (1) the recommended grades have been changed to five stages--A, B, C1, C2, and D; (2) the revisions are consistent with the new International Federation of Gynecology and Obstetrics staging system; (3) the roles are shared between the 'Japanese classification of cervical cancer' and the new guidelines; (4) clinical questions related to adenocarcinoma have been revised; and (5) a clinical question regarding cervical cancer in pregnant patients has been added. Each chapter includes a clinical question, recommendations, background, objectives, explanations, and references. Each recommendation is accompanied by a classification of recommendation categories. The objective of these guidelines is to update the standard treatment strategies for cervical cancer, thus eliminating unnecessary and insufficient treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25800808     DOI: 10.1007/s10147-015-0806-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  3 in total

1.  [Guidelines for proper use of antineoplastic agents. Gynecologic cancer].

Authors:  Kazunori Ochiai; Aiko Okamoto; Noriyuki Katsumata
Journal:  Gan To Kagaku Ryoho       Date:  2002-06

2.  [Guideline for correct use of antineoplastic agents (draft). General theory].

Authors:  Hiroshi Ariyoshi
Journal:  Gan To Kagaku Ryoho       Date:  2002-06

3.  Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

Authors:  Satoru Nagase; Yoshiki Inoue; Naohiko Umesaki; Daisuke Aoki; Masatsugu Ueda; Hideki Sakamoto; Shigemitsu Kobayashi; Ryo Kitagawa; Takafumi Toita; Shoji Nagao; Kiyoshi Hasegawa; Ichio Fukasawa; Keiichi Fujiwara; Yoh Watanabe; Kiyoshi Ito; Hitoshi Niikura; Tsuyoshi Iwasaka; Kazunori Ochiai; Hidetaka Katabuchi; Toshiharu Kamura; Ikuo Konishi; Noriaki Sakuragi; Tadao Tanaka; Yasuo Hirai; Yuji Hiramatsu; Makio Mukai; Hiroyuki Yoshikawa; Tadao Takano; Kosuke Yoshinaga; Takeo Otsuki; Michiko Sakuma; Noriyuki Inaba; Yasuhiro Udagawa; Nobuo Yaegashi
Journal:  Int J Clin Oncol       Date:  2010-03-24       Impact factor: 3.402

  3 in total
  32 in total

1.  Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.

Authors:  Koji Matsuo; Muneaki Shimada; Keiichiro Nakamura; Yuji Takei; Kimio Ushijima; Toshiyuki Sumi; Tatsuru Ohara; Hideaki Yahata; Mikio Mikami; Toru Sugiyama
Journal:  Eur J Surg Oncol       Date:  2019-02-18       Impact factor: 4.424

2.  UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer.

Authors:  Kenji Imai; Takeshi Fukuda; Takuma Wada; Masaru Kawanishi; Reiko Tasaka; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

3.  Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.

Authors:  Mika Okazawa-Sakai; Takanori Yokoyama; Etsuko Fujimoto; Shinichi Okame; Yuko Shiroyama; Takashi Yokoyama; Kazuhiro Takehara
Journal:  Int J Clin Oncol       Date:  2018-02-14       Impact factor: 3.402

4.  Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study.

Authors:  Maki Tanioka; Satoshi Yamaguchi; Muneaki Shimada; Shoji Nagao; Kazuhiro Takehara; Masato Nishimura; Satoshi Morita; Shunichi Negoro; Kiyoshi Fujiwara; Junzo Kigawa
Journal:  Med Oncol       Date:  2017-07-05       Impact factor: 3.064

Review 5.  Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Muneaki Shimada; Shinya Sato; Etsuko Miyagi; Akiko Tozawa-Ono; Nao Suzuki; Masaki Fujimura; Yoichi Aoki; Satoru Sagae; Toru Sugiyama
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

6.  Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.

Authors:  Yuki Mukai; Yumiko Minagawa; Hiromi Inoue; Akiko Sato; Kengo Matsui; Takanori Fukuda; Kazuya Onuma; Hideyuki Hongo; Ryosuke Shirata; Hironori Nagata; Harumitu Hashimoto; Tomio Inoue; Masaharu Hata; Motoko Omura
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.

Authors:  Tong Shu; Dan Zhao; Bin Li; Yating Wang; Shuanghuan Liu; Pingping Li; Jing Zuo; Ping Bai; Rong Zhang; Lingying Wu
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

8.  Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.

Authors:  Yuki Otani; Tatsuya Ohno; Ken Ando; Kazutoshi Murata; Shingo Kato; Shin-Ei Noda; Keiko Murofushi; Hiroki Ushijima; Daisaku Yoshida; Noriyuki Okonogi; Fumiaki Isohashi; Masaru Wakatsuki; Takashi Nakano
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

9.  The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer.

Authors:  Naoya Murakami; Kazuma Kobayashi; Tomoyasu Kato; Satoshi Nakamura; Akihisa Wakita; Hiroyuki Okamoto; Satoshi Shima; Keisuke Tsuchida; Tairo Kashihara; Ken Harada; Kana Takahashi; Rei Umezawa; Koji Inaba; Yoshinori Ito; Hiroshi Igaki; Jun Itami
Journal:  J Contemp Brachytherapy       Date:  2016-10-10

Review 10.  Clinical trials in low and middle-income countries - Successes and challenges.

Authors:  Surbhi Grover; Melody Xu; Anuja Jhingran; Umesh Mahantshetty; Linus Chuang; William Small; David Gaffney
Journal:  Gynecol Oncol Rep       Date:  2016-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.